not surprised to see it selling off after the earlier rise - and honestly, i wouldn't have been surprised if it had been red today. i only say that because i don't put any trust whatsoever in this OTC market that trade on. there are no institutions, no high net worth investors - so it's dominated by retail traders, momentum traders, etc. my gut is that much of the volume over the past several months has been trend followers who are short (based on the last year) and who may have no knowledge of the science, the potential, etc. i also think there are plenty of POS shorts who following Adam Fraudstein and the other scumbags who slam the company.

Thus, i don't try to glean much from the day to day SP. However, today was another chink in the dam - another little piece of evidence of the efficacy of our drug. Taken in isolation, each of these pieces of data may or may not mean much to the SP. But as they accumulate, we'll hit a "point of no return" when the dam bursts. i don't know if that's later this Summer, or later this year - but i would bet we ring in 2022 at a significantly higher price. GL